Section one: Contracting authority
one.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
Contact
Henry Prudden
Country
United Kingdom
NUTS code
UKK11 - Bristol, City of
National registration number
NHS Blood and Transplant
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Provision of Laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors
Reference number
C103467
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
This Prior Information Notice (PIN) is separate to any tender opportunity and its purpose is to consult the market to improve NHSBT’s knowledge of organisations within the marketplace that can offer the required service and to gauge market interest ahead of any further tender opportunity.
two.1.5) Estimated total value
Value excluding VAT: £500,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
- 85145000 - Services provided by medical laboratories
- 85148000 - Medical analysis services
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
The service provision required is laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors to permit safe and legal transplantation of all solid organs.
Donor characterisation is an absolute requirement for safe organ allocation and is mandated in law under the Quality and Safety of Organs Intended for Transplantation Regulations (2012)6. The majority of organs cannot be offered or allocated to recipients until the results for the donor HLA type and microbiology screen are reported.
Donor characterisation is the process of collecting relevant information about the donor to evaluate suitability for organ donation. Organs from DBD and DCD donors can transmit disease; a minimum repertoire of microbiological screening tests is undertaken as mandated by the European Union Organ Donation Directive1 and recommended by The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)2
The information provided contributes to recipient patient safety, minimises the risk of disease transmission, enables risk mitigation and through allocation processes ensures equity of access to organs. Information relating to the donor is used by transplant clinicians in making the decision to either accept or decline an organ and by the potential recipient to inform a decision to either consent to or refuse a transplant from a particular donor.
A robust and efficient laboratory service providing donor characterisation is essential to support organ offering and subsequent transplantation helping to meet the future demands of the organ donation and transplantation programme.
Laboratories will deliver a nationally defined testing service for all consented/authorised eligible organ donors.
Expressions of interest should be e-mailed to Henry.Prudden@nhsbt.nhs.uk by 12:00 hours on Friday 14th October 2022.
two.3) Estimated date of publication of contract notice
6 October 2022
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes